Precision Biosciences (DTIL) Total Debt (2021 - 2026)
Precision Biosciences (DTIL) posted quarterly Total Debt of $22.4 million for Q1 2026, little changed year-over-year from $22.3 million in Q1 2025, and little changed quarter-over-quarter from $22.4 million in Q4 2025.
Precision Biosciences (DTIL) Total Debt (2021 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has reported Total Debt for 6 consecutive years, with $22.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt changed 0.37% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (changed 0.37% YoY), while the FY2025 annual figure was $22.4 million, changed 0.37% from the prior year.
- Total Debt held at $22.4 million in Q1 2026 per DTIL's latest filing, from $22.4 million in the prior quarter.
- Across five years, Total Debt topped out at $22.5 million in Q2 2024 and bottomed at $2.5 million in Q1 2022.
- Historically, Total Debt has averaged $21.2 million across 5 years, with a median of $22.3 million in 2025.
- Annual changes were most pronounced in 2022 — Total Debt soared 809.87% — and 2025, when it fell 0.62%.
- Precision Biosciences' Total Debt stood at $22.2 million in 2022, then rose by 0.85% to $22.4 million in 2023, then decreased by 0.41% to $22.3 million in 2024, then increased by 0.37% to $22.4 million in 2025, then increased by 0.07% to $22.4 million in 2026.
- Business Quant data shows DTIL's Total Debt at $22.4 million in Q1 2026, $22.4 million in Q4 2025, and $22.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 9.34 Bn |
| 10 | Precision Biosciences | 224.69 Mn | 137.15 Mn | - | 22.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.42 Mn |
| Mar 31, 2026 | 22.42 Mn |
| Dec 31, 2025 | 22.40 Mn |
| Sep 30, 2025 | 22.37 Mn |
| Jun 30, 2025 | 22.35 Mn |
| Mar 31, 2025 | 22.34 Mn |
| Dec 31, 2024 | 22.32 Mn |
| Sep 30, 2024 | 22.28 Mn |
| Jun 30, 2024 | 22.49 Mn |
| Mar 31, 2024 | 22.46 Mn |
| Dec 31, 2023 | 22.41 Mn |
| Sep 30, 2023 | 22.37 Mn |
| Jun 30, 2023 | 22.32 Mn |
| Mar 31, 2023 | 22.27 Mn |
| Dec 31, 2022 | 22.22 Mn |
| Sep 30, 2022 | 22.17 Mn |
| Jun 30, 2022 | 22.12 Mn |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.45 Mn |